Consortium for Universal Healthcare Credentialing, Inc.

U.S. Department of Health and Human Services (HHS)

Executive Director Blog: Erin Bass of Dentons on Healthcare Credentialing and Employment Law

2023-09-18T14:31:51-04:0009/18/2023|ANSI/NEMA SC 1-2020 American National Standard for Supplier Credentialing in Healthcare, C4UHC News, Center for Supply Chain Studies (CSCS), Comments ON, Consortium for Universal Healthcare Credentialing Inc., Dentons, Discussion, Erin Bass, Executive Director, Executive Director Blog, Patient Care, Patient Safety, Sharon Gleason, Standards, U.S. Department of Health and Human Services (HHS)|

Erin Bass, a partner at Dentons, the largest law firm globally, discusses her role in advising employers across the United States on complying with a myriad of employment laws with C4UHC Executive Director, Sharon Gleason, Ed.D.

Read More

Executive Director Blog: Eric Berlin of Dentons Speaks About Medical Marijuana

2023-05-30T15:18:15-04:0005/30/2023|C4UHC News, Cannabis, Center for Supply Chain Studies (CSCS), Comments ON, Consortium for Universal Healthcare Credentialing Inc., Dentons, Discussion, Executive Director, Executive Director Blog, Medical Marijuana, Patient Care, Patient Safety, Sharon Gleason, Standards, U.S. Department of Health and Human Services (HHS)|

Eric Berlin, one of the leading cannabis lawyers in the U.S. with Dentons, the largest law firm in the world, says in his interview with C4UHC Executive Director, Sharon Gleason, Ed.D., hospitals and medical centers need to recognize the disruptive impact that legal cannabis is having on employee and vendor testing.

Read More

©2023 Consortium for Universal Healthcare Credentialing, Inc. (C4UHC)

Web site by Mitra Creative

Antitrust Message

C4UHC is committed to maintaining the highest level of ethical standards in strict compliance with antitrust laws. Nothing discussed at our meetings is intended to result in an agreement on price, exclude suppliers from any market, or otherwise restrain competition. Members are instructed to avoid discussion of competitively sensitive subjects, including costs, prices, sales, product marketing, and other confidential information.
CONFIRM
close-link
Go to Top